Group B Streptococcal Disease
New England Journal of Medicine · 26.02.2026 · 394 (9) · 896-905
DOI: 10.1056/nejmra2313146 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift New England Journal of Medicine, erschienen am 26.02.2026. Verfasst von Karen M Puopolo. Beteiligte Einrichtung: University of Pennsylvania Perelman School of Medicine, Philadelphia. Hauptthemen laut MEDLINE: Pregnancy Complications, Infectious, Streptococcal Infections, Streptococcus agalactiae. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 74 Literaturangaben.
Abstract (Originalsprache)
Group B streptococcus commonly colonizes the human gastrointestinal and genitourinary tracts and is the single most common bacterial cause of invasive infection among newborns in the United States. Intrapartum antibiotic prophylaxis is currently used to reduce the risk of group B streptococcal disease among pregnant persons and newborns. No strategies are currently available to prevent disease in later infancy or among nonpregnant adults. Vaccines against group B streptococcal disease that consist of capsular polysaccharides linked to protein antigens are in development and may provide a means of prevention for all at-risk populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Pennsylvania Perelman School of Medicine, Philadelphia.
- Division of Neonatology and Clinical Futures, Children's Hospital of Philadelphia, Philadelphia.
- Section on Newborn Medicine, Pennsylvania Hospital, Philadelphia.
ORCID-Profile: Karen M Puopolo
Zitieren
APA
Puopolo, K. M. (2026). Group B Streptococcal Disease. New England Journal of Medicine, 394(9), 896-905. https://doi.org/10.1056/nejmra2313146
Vancouver
Puopolo KM. Group B Streptococcal Disease. New England Journal of Medicine. 2026;394(9):896-905. doi:10.1056/nejmra2313146
BibTeX
@article{Puopolo2026,
author = {Puopolo, Karen M},
title = {Group B Streptococcal Disease},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {9},
pages = {896--905},
doi = {10.1056/nejmra2313146}
}
EUVIMED